Furthermore, an in vivo study revealed that SIRT3−/− mice were more susceptible to NIHL, and SIRT3 −/− mice treated with nicotinamide riboside exhibited less protection from both TTS and PTS after noise exposure [31]. The gene discussed is SIRT3; the disease is noise induced hearing loss.